STUDY VALIDATES BREVAGen MORE ACCURATELY IDENTIFIES BREAST CANCER RISK LEADING TO INCREASED BREAST HEALTH COMPLIANCE
April 15, 2013 12:06 ET
|
Genetic Technologies Group
CHARLOTTE, N.C., April 15, 2013 (GLOBE NEWSWIRE) -- Phenogen Sciences, Inc. recently presented study results demonstrating that BREVAGen™, a first-in-class, scientifically-validated predictive...
The Centers for Women's Health in Stamford CT Pioneers Breast Cancer Risk Assessment
March 18, 2013 12:14 ET
|
Genetic Technologies Group
STAMFORD, Conn., March 18, 2013 (GLOBE NEWSWIRE) -- Dr. Joel Evans, Founder and Director of The Center for Women's Health, is one of the first physicians in the nation to make the BREVAGen™...
Noble Hospital Comprehensive Breast Program in Massachusetts Pioneers Breast Cancer Risk Assessment
January 14, 2013 10:15 ET
|
Noble Hospital
SPRINGFIELD, Mass., Jan. 14, 2013 (GLOBE NEWSWIRE) -- Dr. Steven Schonholz, Director of the Comprehensive Breast Program at Noble Hospital, is one of the first physicians in the nation to make the...
Primary Care Associates of Bellevue Pioneers Breast Cancer Risk Assessment
September 24, 2012 12:16 ET
|
Primary Care Associates P.S.
BELLEVUE, WASH., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Dr. Lisa Steffensen of Primary Care Associates is one of the first physicians in the nation to make the BREVAGen™ predictive risk test...